维升药业进博首秀:“全球创新、中国加速”战略持续落地

环球网
Nov 07, 2025

11月5日,内分泌领域创新药企维升药业首次以参展商身份亮相第八届中国国际进口博览会,携两款全球创新药物重磅登场——“全球首创”药物帕罗培特立帕肽凭借其卓越创新性入选本届“进博好物”;另一致力于成为“潜在同类最佳”药物隆培生长激素也同步首展,充分彰显维升药业“全球创新、中国加速”的战略实践。合作协议签约仪式现场进博会期间,维升药业先后与国内制药装备龙头企业东富龙科技集团达成双腔冻干制剂技术战略合作,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10